Five Duke Researchers Receive NIH Awards
Three researchers at Duke University Medical Center received prestigious young innovators awards from The National Institutes of Health, and two others won competitive grants to study kidney and urologic disease.
Sept. 13, 2012
Newest Screen For Newborns Will Indicate Heart Problems
About one in every 120 babies are born with congenital heart disease (CHD), of which about 25 percent is critical, requiring special care early in life. CHD is responsible for more deaths in the first year of life than any other birth defect, but often outcomes can be improved with early detection.
Aug. 22, 2011
New National Initiative to Rigorously Study Pediatric Dosing and Safety of Prescription Medicines
A groundbreaking effort to reduce the risks and dangers faced everyday by millions of children who are prescribed medications that lack definitive data about pediatric dosing, efficacy and safety was created today through an initiative supported by the National Institutes of Health (NIH), totaling up to $95 million over the next seven years. The initiative, a Pediatric Trials Network (PTN), will be led through a collaboration between the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the Best Pharmaceuticals for Children Act (BPCA) Program, and the Duke Clinical Research Institute (DCRI), and will involve the participation of several of the country's preeminent pediatric medicine experts, hospitals and medical centers.
Sept. 30, 2010
Questions Abound as Pediatric Clinical Trials Move Overseas
The majority of pediatric clinical trials conducted under a Congressional provision granting patent extensions to pharmaceutical companies in exchange for performing research on drug safety and efficacy in children involve sites outside the United States, raising scientific and ethical questions, according to researchers at Duke Clinical Research Institute.
Aug. 23, 2010